MIR548H1: A Potential Drug Target and Biomarker (G100313830)
MIR548H1: A Potential Drug Target and Biomarker
Molecular data has revolutionized our understanding of hematological diseases, and hematoxylin-containing proteins (HCP) have been identified as potential drug targets in various diseases, including cancer. The MIR548H1 gene, located on chromosome 18, has been identified as an HCP that has been expressed in various tissues and is involved in cell signaling pathways. In this article, we will discuss the potential implications of MIR548H1 as a drug target and biomarker.
Structure and Function
MIR548H1 is a 21-kDa protein that is expressed in various tissues, including bone marrow, spleen, and peripheral blood. It is a member of the MIR family of transmembrane proteins, which are involved in various signaling pathways, including cell adhesion, migration, and invasion. MIR548H1 is composed of a unique transmembrane domain, a catalytic domain, and a cytoplasmic tail.
The MIR548H1 gene has been implicated in various cellular processes, including cell adhesion, migration, and the regulation of cell cycle progression. MIR548H1 has been shown to be involved in the regulation of mitochondrial function and to play a role in the development of cancer.
Potential Drug Target
MIR548H1 is a potential drug target due to its unique structure and function. The transmembrane domain of MIR548H1 allows it to interact with various signaling molecules, including tyrosines and estrogens. The catalytic domain of MIR548H1 has been shown to play a role in the regulation of cellular processes, including cell adhesion and migration.
MIR548H1 has also been shown to be involved in the regulation of cell cycle progression, which is a key factor in cancer development. The cytoplasmic tail of MIR548H1 has been shown to interact with the microtubules of the
Protein Name: MicroRNA 548h-1
The "MIR548H1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR548H1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR548H2 | MIR548H3 | MIR548H4 | MIR548H5 | MIR548I1 | MIR548I2 | MIR548I3 | MIR548I4 | MIR548J | MIR548K | MIR548L | MIR548M | MIR548N | MIR548O | MIR548O2 | MIR548P | MIR548Q | MIR548S | MIR548T | MIR548U | MIR548V | MIR548W | MIR548X | MIR548Y | MIR549A | MIR550A1 | MIR550A2 | MIR550A3 | MIR550B1 | MIR550B2 | MIR551A | MIR551B | MIR552 | MIR553 | MIR554 | MIR555 | MIR556 | MIR557 | MIR5571 | MIR5572 | MIR5579 | MIR558 | MIR5580 | MIR5581 | MIR5582 | MIR5583-1 | MIR5584 | MIR5585 | MIR5586 | MIR5587 | MIR5588 | MIR5589 | MIR559 | MIR5590 | MIR5591 | MIR561 | MIR562 | MIR563 | MIR564 | MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697 | MIR5698 | MIR5699 | MIR570 | MIR5700 | MIR5701-1 | MIR5701-2 | MIR5701-3 | MIR5702 | MIR5703 | MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG
